• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail
-

Diversity in Clinical Trials

Description: In support of the FDASIA Section 907 Action Plan to Enhance the Collection and Availability of Demographic Subgroup Data, OMH will conduct outreach to minority audiences to increase awareness about the importance of diverse participation in clinical trials.

Briefing Status: ON TRACK

Prior Briefing Status: ON TRACK

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date
A. Update website with information about clinical trial diversity (9/30/2017)
(12/31/2017)
(9/30/2018)
(12/31/2018)
(12/31/2019)
12/31/2020
On Track
B. Develop health education materials about clinical trial diversity for minorities (9/30/2017)
(12/31/2017)
(9/30/2018)
(12/31/2018)
(12/31/2019)
12/31/2020
On Track
C. Develop and disseminate multi-media campaign about clinical diversity. 12/31/2020
On Track

Foot Notes

  • The dates in italics are modified milestone due dates that have been updated due to real-time delays.

Key Projects Legend

Milestone StatusDefinition
Not Yet StartedWork for specific milestone has not yet been started.
CompletedMilestone and/or overall project is completed.
On TrackMilestone - On track for completion by milestone deadline. Quarter status - Project is on track for completion based on overall milestone status.
On HoldMilestone - On hold, but deadline for completion has not passed. Quarter status - Project is on hold, based on overall milestone status.
DelayedMilestone - Delayed as it has not been completed and deadline has passed. Quarter status - Project is delayed based on overall milestone status.

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.

-
-